Malkin, M G <br/><br/>
Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group.  [electronic resource] 

 -  Journal of neuro-oncology  1994 
 - 55-65 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0167-594X 
<br/><br/><label>Standard No.: </label>10.1007/BF01058355  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents<br/>Aziridines--adverse effects<br/>Benzoquinones--adverse effects<br/>Brain Neoplasms--drug therapy<br/>Child<br/>Humans<br/>Middle Aged<br/>Nitrosourea Compounds--adverse effects<br/>Prospective Studies<br/>Recurrence<br/>Survival Analysis